PAVmed Inc (PAVM) - Total Assets
Based on the latest financial reports, PAVmed Inc (PAVM) holds total assets worth $38.07 Million USD as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
PAVmed Inc - Total Assets Trend (2014–2024)
This chart illustrates how PAVmed Inc's total assets have evolved over time, based on quarterly financial data. Also see PAVmed Inc (PAVM) total market value for the company's overall valuation and market capitalisation.
PAVmed Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
PAVmed Inc's total assets of $38.07 Million consist of 7.1% current assets and 92.9% non-current assets. Review PAVM total debt and obligations to assess the company's total debt and financial obligations.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 3.9% |
| Accounts Receivable | $18.00K | 0.1% |
| Inventory | $266.00K | 0.9% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2014–2024)
This chart illustrates how PAVmed Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See PAVM live share price for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: PAVmed Inc's current assets represent 7.1% of total assets in 2024, a decrease from 100.0% in 2014.
- Cash Position: Cash and equivalents constituted 3.9% of total assets in 2024, down from 99.6% in 2014.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2014.
- Asset Diversification: The largest asset category is inventory at 0.9% of total assets.
PAVmed Inc Competitors by Total Assets
Key competitors of PAVmed Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Medtronic plc
SA:MDTC34
|
Brazil | R$93.03 Billion |
|
Demant A/S
CO:DEMANT
|
Denmark | Dkr39.07 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.89 Billion |
|
Jafron Biomedical Co Ltd
SHE:300529
|
China | CN¥5.20 Billion |
|
Sinocare Inc
SHE:300298
|
China | CN¥6.25 Billion |
|
Emvision Medical Devices Ltd
AU:EMV
|
Australia | AU$24.94 Million |
|
Theradiag SA
PA:ALTHE
|
France | €11.55 Million |
|
Biosynex
PA:ALBIO
|
France | €149.44 Million |
PAVmed Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.40 | 0.06 | 0.94 |
| Quick Ratio | 0.38 | 0.05 | 0.89 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-6.27 Million | $-35.43 Million | $-1.31 Million |
PAVmed Inc - Advanced Valuation Insights
This section examines the relationship between PAVmed Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.14 |
| Latest Market Cap to Assets Ratio | 0.12 |
| Asset Growth Rate (YoY) | -7.4% |
| Total Assets | $30.66 Million |
| Market Capitalization | $3.66 Million USD |
Valuation Analysis
Below Book Valuation: The market values PAVmed Inc's assets below their book value (0.12x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: PAVmed Inc's assets decreased by 7.4% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for PAVmed Inc (2014–2024)
The table below shows the annual total assets of PAVmed Inc from 2014 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $30.66 Million | -7.42% |
| 2023-12-31 | $33.12 Million | -38.65% |
| 2022-12-31 | $53.98 Million | -37.94% |
| 2021-12-31 | $86.98 Million | +339.76% |
| 2020-12-31 | $19.78 Million | +173.16% |
| 2019-12-31 | $7.24 Million | -14.78% |
| 2018-12-31 | $8.50 Million | +418.18% |
| 2017-12-31 | $1.64 Million | +88.38% |
| 2016-12-31 | $870.42K | -28.31% |
| 2015-12-31 | $1.21 Million | +44.18% |
| 2014-12-31 | $842.08K | -- |
About PAVmed Inc
PAVmed Inc. engages in acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cell Collection Device, which consists of diagnostic test that serves as a testing… Read more